PMID- 16951768 OWN - NLM STAT- MEDLINE DCOM- 20070518 LR - 20151119 IS - 0379-5284 (Print) IS - 0379-5284 (Linking) VI - 27 IP - 9 DP - 2006 Sep TI - Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast? PG - 1329-33 AB - OBJECTIVE: To determine the association between thymidine phosphorylase (TP) and angiogenesis, and other conventional prognostic markers. We also evaluated interobserver and intraobserver reliability for TP expression in ductal carcinoma, to achieve a more consistent results. METHODS: Our study included all cases diagnosed in Adnan Menderes University Medical Faculty Hospital, Aydin, Turkey as invasive ductal carcinoma or ductal carcinoma in situ (DCIS) with proven component of (>30%), between January 2003 and February 2005. The total number of the cases was 27 and their median age was 50 years. All sections were stained using monoclonal antibody-TP and examined at x40 magnification. Either nuclear or cytoplasmic staining was accepted as positive. The histoscore (H-score) was calculated for each specimen. The tumor stromal vascularity was assessed by monoclonal anti-CD34; and areas of intense vascularization were determined. Conventional immunohistochemical markers such as c-erb B2, Ki-67, estrogen and progesterone receptors and p53 were also applied to all slides. Three pathologists blindly examined each slide under 10 high-power fields (10 HPF) for 2 times in a 2 months period. RESULTS: There was no significant association between stromal vascularity and TP staining of cancer cells (p=0.1) and no correlation was determined between H-scores for TP staining in ductal carcinoma and DCIS components (p=0.5). CONCLUSION: There was no significant correlation noted between stromal and periductal vascularity with the anti-CD34 antibody was used. No significant correlation was identified between the TP H-score and stromal or periductal vascularity. FAU - Erkus, Muhan AU - Erkus M AD - Department of Pathology, Faculty of Medicine, Adnan Menderes University, Aydin 09100, Turkey. muhanerkus@hotmail.com FAU - Meteoglu, Ibrahim AU - Meteoglu I FAU - Culhaci, Nil AU - Culhaci N FAU - Meydan, Nezih AU - Meydan N FAU - Erdogdu, Ibrahim AU - Erdogdu I LA - eng PT - Journal Article PL - Saudi Arabia TA - Saudi Med J JT - Saudi medical journal JID - 7909441 RN - 0 (Antigens, CD34) RN - 0 (Biomarkers, Tumor) RN - EC 2.4.2.4 (Thymidine Phosphorylase) SB - IM MH - Adult MH - Aged MH - Antigens, CD34/analysis/metabolism MH - Biomarkers, Tumor/analysis/metabolism MH - Breast Neoplasms/blood supply/*metabolism/pathology MH - Carcinoma, Ductal, Breast/blood supply/*metabolism/pathology MH - Carcinoma, Intraductal, Noninfiltrating/blood supply/*metabolism/pathology MH - Female MH - Humans MH - Immunohistochemistry MH - Middle Aged MH - Neovascularization, Pathologic/*metabolism MH - Observer Variation MH - Prognosis MH - Thymidine Phosphorylase/analysis/*metabolism MH - Turkey EDAT- 2006/09/05 09:00 MHDA- 2007/05/19 09:00 CRDT- 2006/09/05 09:00 PHST- 2006/09/05 09:00 [pubmed] PHST- 2007/05/19 09:00 [medline] PHST- 2006/09/05 09:00 [entrez] AID - 20060285' [pii] PST - ppublish SO - Saudi Med J. 2006 Sep;27(9):1329-33.